Join Futurist Eric Fry for The Road to AGI Summit

A secretive, controversial AI development could soon reinvent the world we live in. Eric Fry shows you where to move your money before it’s too late.

Thu, August 22 at 1:00PM ET
 
 
 
 
Reserve Your Spot

Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Tilray Stock Is Not Very Different Since Its Aphria Merger

By Alex Sirois, InvestorPlace Contributor
TLRY stock could end up as a force in the cannabis sector, but investors' fears and hesitation and legalization remain unchanged.

Avoid the CDC Soap Opera and Skip Carnival Stock for Now

By David Moadel, InvestorPlace Contributor
Even as Carnival struggles to get its cruise ships sailing again, CCL stock trades at short-term highs and could soon face price pressure.

Churchill Capital IV’s Merger With Lucid Motors Is Stalled Until Summer

By Will Ashworth, InvestorPlace Contributor
Lucid Motors has had little to report in recent weeks. With few catalysts, CCIV stock had nowhere to go but down. Has anything changed? 

The Pros and Cons of Rolling the Dice on Northern Dynasty Minerals Stock

By Thomas Niel, InvestorPlace Contributor
Lacking support not just from Washington politicians and regulators, but the local community as well, the odds of this junior miner prevailing are probably more remote than what's currently baked into the NAK stock price.

Zomedica Stock Is At Serious Risk Unless Bulls Commit

By Nicolas Chahine, InvestorPlace Contributor
ZOM stock makes for a better trading vehicle than an investment in spite of their noble effort to heal. It needs to hold recent lows or else.

BlackBerry Stock Is Starting To Approach Buy Territory but Not Just Yet

By Mark R. Hake, CFA
BlackBerry stock is starting to approach buy territory but not just yet. BB stock is still too high until earnings rise to 38 cents by early 2024, especially if it sells its mobile patents.

MicroVision Is Becoming an Almost Perfect Casino Play

By Josh Enomoto, InvestorPlace Contributor
MVIS stock has been all over the map this year. The crazy thing is, this volatility is about the only thing going for MicroVision.

Wind Turbines Could Power General Electric’s Turnaround

By David Moadel, InvestorPlace Contributor
GE stock has some catching up to do before it returns to its previous long-term peak. A focus on renewable energy could help achieve this.

Boeing Investors Should Anticipate a Slow, Steady Recovery

By David Moadel, InvestorPlace Contributor
After a mix of good and bad news, Boeing is ready to improve its plane delivery. This can forge the path for a gradual rise in BA stock.

Hold Asensus Surgical Stock as Next-Gen Senhance System Gains Traction

By Louis Navellier and the InvestorPlace Research Staff
ASXC stock holders should appreciate the company's ambitious vision as Asensus introduces its innovative surgical tech into multiple regions.

What is PLTR Stock Worth As Shares Fade Badly?

By Chris Lau, InvestorPlace Contributor
Palantir investors have a wall of worry to climb, hurt by insider selling and paltry revenue in the short-term period.

Vaxart Could Still Be a Viable Covid 19 Vaccine Play

By Muslim Farooque, InvestorPlace Contributor
VXRT Stock needs to nail the next few studies of its Covid 19 vaccine candidate and prove its thesis to widen its bull case significantly

A New CEO Means a Bright Future for Amazon

By Dana Blankenhorn, InvestorPlace Contributor
To build a legacy, incoming Amazon CEO Andy Jassy will be motivated to raise confidence in AMZN stock and innovate in competitive sectors.

It’s Really Do or Die for Naked Brand

By Josh Enomoto, InvestorPlace Contributor
Some evidence suggests that NAKD stock may have hit a bottom, but this remains one of the riskiest ideas in the market.

Coupang Needs to Focus on Regaining Investor Trust

By Josh Enomoto, InvestorPlace Contributor
While Coupang produced strong revenue for its first earnings report as a public company, its growth focus may be a liability.

Hyliion Stock Has a Good Story, but It’s Too Risky at These Prices

By Larry Ramer, InvestorPlace Contributor
There's a great deal to like about Hyliion, but the risk-reward ratio of HYLN stock is negative at this point.

As Marijuana Businesses Merge, Don’t Forget About Canopy Growth

By David Moadel, InvestorPlace Contributor
In a time of cannabis market consolidation, some folks seems to have forgotten about CGC stock. Yet, Canopy is still a important company.

Compass Pathways Offers Chance on Exploratory Mental Health Treatments

By David Moadel, InvestorPlace Contributor
Over the past year, CMPS stock has been going nowhere fast. However, there's been recent progress in advancing psilocybin-assisted therapy.

TPG Pace Beneficial Finance Stock Is Still Risky Despite the Discount

By Josh Enomoto, InvestorPlace Contributor
TPGY stock is on a heavy discount but that could be a good reason: EVs simply have a long way to go before becoming mainstream.
Load More Articles